Neuro-Oncology Branch, National Cancer Institute (NCI/NIH)
Fairfax, United States
Tyrone Dowdy, M.Sc. (NCI/NIH) is a research technician from the Cancer Metabolism Research Group of Neuro-Oncology Branch (NOB) at the National Cancer Institute. He has extensive experience in metabolomic and lipidomic research and specializes in LC/MS analysis with emphasis on method development, carbon tracing, metabolomics, lipidomics, drug discovery and mechanism of action studies as well as pharmacokinetic and quantitative analysis.
During graduate studies at George Mason University, he attained Master of Science in Chemistry with an emphasis on biochemistry and research in drug discovery and natural products. Thereafter, he joined Proteomic & Metabolomic Shared Resource Center at Lombardi Comprehensive Cancer Center of Georgetown University. Current research at NOB investigates the role that cancer metabolomics has on distinguishing heterogeneous subtypes of cancers (particularly gliomas), and the discovery of unique vulnerabilities and drug-resistance within those subtypes. The primary aim is to elucidate effective therapeutic interventions and to investigate the links between cancer metabolism, progression and treatment responses.